Category: PRNews

SEONGNAM, South Korea, Dec. 27, 2018 /PRNewswire/ — Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, announced that the company has successfully activated clinical study…

BANGKOK, Dec. 28, 2018 /PRNewswire/ — Investment incentive schemes under the 7-year strategic investment promotion policy (2015-2021) have been confirmed to contribute 418 billion baht to Thailand’s GDP growth, according…

Korea-based healthcare firm Exosystems will showcase its newly-launched exoRehab at CES 2019 in Las Vegas LAS VEGAS, Dec. 27, 2018 /PRNewswire/ — South Korean healthcare wearables maker Exosystems, a member…

SUZHOU, China, Dec. 27, 2018 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company (“Lilly”) jointly announce today that the co-developed Tyvyt® (fully human anti-PD-1 therapeutic…

DARMSTADT, Germany, Dec. 20, 2018 /PRNewswire/ — Not intended for distribution in the USA, Canada or UK Agreement enables Merck to maintain an investment in the rapidly advancing oncology field…

Enables Hong Kong Residents to Receive Healthcare Services in mainland China and Reduce Medical Costs HONG KONG, Dec. 20, 2018 /PRNewswire/ — The first innovative and integrated healthcare services platform…

MOUNTAIN VIEW, Calif., Dec. 24, 2018 /PRNewswire/ — CooTek (NYSE: CTK), the developer of the feminine care app called Cherry, has launched a daily health report feature, providing customized healthcare…

SHANGHAI, Dec. 25, 2018 /PRNewswire/ — ICSE China 2019, hosted by CCCMHPIE, UBM EMEA and UBM Sinoexpo, will take place again in Hall E2/E7 of Shanghai New International Expo Centre…

SUZHOU, China, Dec. 21, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) today announced the successful enrollment and dosing of the first three patients in a Phase I clinical trial in the…

— The first I-Mab proprietary drug candidate to enter clinical trials in the United States SHANGHAI, Dec. 24, 2018 /PRNewswire/ — I-Mab Biopharma (I-Mab), a China-based clinical stage biopharmaceutical company…